Cardiovascular diseases remain a leading cause of mortality worldwide. In spite of innovative treatments, both through pharmacological and interventional approaches, CVD continue to progress, especially because of the increased incidence of diseases, such as diabetes or other well-established CV risk factors, but also because of cumulative comorbidities and emerging risk factors (sleep disorders, chronic inflammation, psychiatric disorders, etc.).
In this Special Issue dedicated to Risk Factors, Comorbidities and Prevention, we are interested in advances to struggle comorbidities. Here, we will present new tools including new modalities of imaging, with translation regarding valvular disease and MRI, but also how to use them in order to guide the management of dyslipidemia. Last but not least, new approaches address well-established pathways not taken into consideration until now, such as inflammation.
Date: 29 September 2022
Time: 3:30 pm CEST | 8:30 am CDT | 9:30 am EDT | 9:30 pm CST Asia
Webinar ID: 810 1318 7449
Webinar Secretariat: jcm.webinar@mdpi.com